Sarah M Bartsch1,2, Kim F Wong3, Owen J Stokes-Cawley1,2, James A McKinnell4,5, Chenghua Cao6,7, Gabrielle M Gussin6,7, Leslie E Mueller1,2, Diane S Kim6,7, Loren G Miller5, Susan S Huang6,7, Bruce Y Lee1,2. 1. Public Health Computational and Operations Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Global Obesity Prevention Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Center for Simulation and Modeling, University of Pittsburgh, Pennsylvania. 4. Infectious Disease Clinical Outcomes Research Unit, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, California. 5. Torrance Memorial Medical Center, Torrance, California. 6. Division of Infectious Diseases, University of California-Irvine Health School of Medicine, Irvine, California. 7. Health Policy Research Institute, University of California-Irvine Health School of Medicine, Irvine, California.
Abstract
BACKGROUND: Clinical testing detects a fraction of carbapenem-resistant Enterobacteriaceae (CRE) carriers. Detecting a greater proportion could lead to increased use of infection prevention and control measures but requires resources. Therefore, it is important to understand the impact of detecting increasing proportions of CRE carriers. METHODS: We used our Regional Healthcare Ecosystem Analyst-generated agent-based model of adult inpatient healthcare facilities in Orange County, California, to explore the impact that detecting greater proportions of carriers has on the spread of CRE. RESULTS: Detecting and placing 1 in 9 carriers on contact precautions increased the prevalence of CRE from 0% to 8.0% countywide over 10 years. Increasing the proportion of detected carriers from 1 in 9 up to 1 in 5 yielded linear reductions in transmission; at proportions >1 in 5, reductions were greater than linear. Transmission reductions did not occur for 1, 4, or 5 years, varying by facility type. With a contact precautions effectiveness of ≤70%, the detection level yielding nonlinear reductions remained unchanged; with an effectiveness of >80%, detecting only 1 in 5 carriers garnered large reductions in the number of new CRE carriers. Trends held when CRE was already present in the region. CONCLUSION: Although detection of all carriers provided the most benefits for preventing new CRE carriers, if this is not feasible, it may be worthwhile to aim for detecting >1 in 5 carriers.
BACKGROUND: Clinical testing detects a fraction of carbapenem-resistant Enterobacteriaceae (CRE) carriers. Detecting a greater proportion could lead to increased use of infection prevention and control measures but requires resources. Therefore, it is important to understand the impact of detecting increasing proportions of CRE carriers. METHODS: We used our Regional Healthcare Ecosystem Analyst-generated agent-based model of adult inpatient healthcare facilities in Orange County, California, to explore the impact that detecting greater proportions of carriers has on the spread of CRE. RESULTS: Detecting and placing 1 in 9 carriers on contact precautions increased the prevalence of CRE from 0% to 8.0% countywide over 10 years. Increasing the proportion of detected carriers from 1 in 9 up to 1 in 5 yielded linear reductions in transmission; at proportions >1 in 5, reductions were greater than linear. Transmission reductions did not occur for 1, 4, or 5 years, varying by facility type. With a contact precautions effectiveness of ≤70%, the detection level yielding nonlinear reductions remained unchanged; with an effectiveness of >80%, detecting only 1 in 5 carriers garnered large reductions in the number of new CRE carriers. Trends held when CRE was already present in the region. CONCLUSION: Although detection of all carriers provided the most benefits for preventing new CRE carriers, if this is not feasible, it may be worthwhile to aim for detecting >1 in 5 carriers.
Authors: Andrea L Cromer; Svitlana O Hutsell; Susan C Latham; Kathy G Bryant; Bonnie B Wacker; Sheila A Smith; Heather A Bendyk; Gregory T Valainis; Michelle C Carney Journal: Am J Infect Control Date: 2004-12 Impact factor: 2.918
Authors: Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: N Feldman; A Adler; N Molshatzki; S Navon-Venezia; E Khabra; D Cohen; Y Carmeli Journal: Clin Microbiol Infect Date: 2013-01-17 Impact factor: 8.067
Authors: Bruce Y Lee; Sarah M Bartsch; Mary K Hayden; Joel Welling; Jay V DePasse; Sarah K Kemble; Jim Leonard; Robert A Weinstein; Leslie E Mueller; Kruti Doshi; Shawn T Brown; William E Trick; Michael Y Lin Journal: Clin Infect Dis Date: 2020-02-14 Impact factor: 9.079
Authors: Bruce Y Lee; Sarah M Bartsch; Kim F Wong; S Levent Yilmaz; Taliser R Avery; Ashima Singh; Yeohan Song; Diane S Kim; Shawn T Brown; Margaret A Potter; Richard Platt; Susan S Huang Journal: Health Aff (Millwood) Date: 2012-10 Impact factor: 6.301
Authors: Bruce Y Lee; Sarah M Bartsch; Kim F Wong; James A McKinnell; Eric Cui; Chenghua Cao; Diane S Kim; Loren G Miller; Susan S Huang Journal: Am J Epidemiol Date: 2016-02-11 Impact factor: 4.897
Authors: Rachel B Slayton; Damon Toth; Bruce Y Lee; Windy Tanner; Sarah M Bartsch; Karim Khader; Kim Wong; Kevin Brown; James A McKinnell; William Ray; Loren G Miller; Michael Rubin; Diane S Kim; Fred Adler; Chenghua Cao; Lacey Avery; Nathan T B Stone; Alexander Kallen; Matthew Samore; Susan S Huang; Scott Fridkin; John A Jernigan Journal: MMWR Morb Mortal Wkly Rep Date: 2015-08-07 Impact factor: 17.586
Authors: Alainna J Jamal; Amna Faheem; Lubna Farooqi; Xi Zoe Zhong; Irene Armstrong; David A Boyd; Emily Borgundvaag; Brenda L Coleman; Karen Green; Kithsiri Jayasinghe; Jennie Johnstone; Kevin Katz; Philipp Kohler; Angel X Li; Laura Mataseje; Roberto Melano; Matthew P Muller; Michael R Mulvey; Sarah Nayani; Samir N Patel; Aimee Paterson; Susan Poutanen; Anu Rebbapragada; David Richardson; Alicia Sarabia; Shumona Shafinaz; Andrew E Simor; Barbara M Willey; Laura Wisely; Allison J McGeer Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Bruce Y Lee; Sarah M Bartsch; Michael Y Lin; Lindsey Asti; Joel Welling; Leslie E Mueller; Jim Leonard; Shawn T Brown; Kruti Doshi; Sarah K Kemble; Elizabeth A Mitgang; Robert A Weinstein; William E Trick; Mary K Hayden Journal: Am J Epidemiol Date: 2021-02-01 Impact factor: 4.897
Authors: Sarah M Bartsch; Kim F Wong; Leslie E Mueller; Gabrielle M Gussin; James A McKinnell; Thomas Tjoa; Patrick T Wedlock; Jiayi He; Justin Chang; Shruti K Gohil; Loren G Miller; Susan S Huang; Bruce Y Lee Journal: JAMA Netw Open Date: 2021-08-02